Retinal disease course in Usher syndrome 1B due to MYO7A mutations

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 7924-7936

  Jacobson, Samuel G ^a   Cideciyan, Artur V ^a   Gibbs, Dan ^b   Sumaroka, Alexander ^a   Roman, Alejandro J ^a   Aleman, Tomas S ^a   Schwartz, Sharon B ^a   Olivares, Melani B ^a   Russell, Robert C ^a   Steinberg, Janet D ^a   Kenna, Margaret A ^c   Kimberling, William J ^d,e   Rehm, Heidi L ^f   Williams, David S ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN VIIA; MYOSIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; DARK ADAPTATION; DISEASE COURSE; ELECTRORETINOGRAPHY; EYE EXAMINATION; FEMALE; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; MYOSIN 7A GENE; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PHOTORECEPTOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA CONE; RETINA ROD; USHER SYNDROME; USHER SYNDROME 1B; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHOTORECEPTOR CELL; PHYSIOLOGY; RETINA DEGENERATION; VISUAL DISORDER; VISUAL FIELD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DARK ADAPTATION; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOSINS; PHENOTYPE; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DEGENERATION; TOMOGRAPHY, OPTICAL COHERENCE; USHER SYNDROMES; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS; YOUNG ADULT;

EID: 84855170002     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8313     Document Type: Article

References (60)

1. Saihan Z, Webster AR, Luxon L, Bitner-Glindzicz M. Update on Usher syndrome. Curr Opin Neurol. 2009;22:19-27.
2. Yan D, Liu XZ. Genetics and pathological mechanisms of Usher syndrome. J Hum Genet. 2010;55:327-335.
3. Millán JM, Aller E, Jaijo T, Blanco-Kelly F, Gimenez-Pardo A, Ayuso C. An update on the genetics of Usher syndrome. J Ophthalmol. 2011;2011:417217.
4. Maerker T, van Wijk E, Overlack N, et al. A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. Hum Mol Genet. 2008;17:71-86.
5. Yang J, Liu X, Zhao Y, et al. Ablation of whirling long isoform disrupts the USH2 protein complex and causes vision and hearing loss. PLoS Genetics. 2010; 6(5):e1000955.
6. Williams DS. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res. 2008; 48:433-441.
7. Lentz JJ, Gordon WC, Farris HE, et al. Deafness and retinal degeneration in a novel USH1C knock-in mouse model. Dev Neurobiol. 2010;70:253-267.
8. Hashimoto T, Gibbs D, Lillo C, et al. Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B. Gene Ther. 2007;14:584-594.
9. Jacobson SG, Cideciyan AV, Aleman TS, et al. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Hum Mol Genet. 2008;17:2405-2415.
10. Jacobson SG, Aleman TS, Sumaroka A, et al. Disease boundaries in the retina of patients with Usher syndrome caused by MYO7A gene mutations. Invest Ophthalmol Vis Sci. 2009;50:1886-1894.
11. Williams DS, Aleman TS, Lillo C, et al. Harmonin in the murine retina and the retinal phenotypes of Ush1c-mutant mice and human USH1C. Invest Ophthalmol Vis Sci. 2009;50:3881-3889.
12. Jacobson SG, Roman AJ, Aleman TS, et al. Normal central retinal function and structure preserved in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2010;51:1079-1085.
13. Fishman GA, Kumar A, Joseph ME, Torok N, Anderson RJ. Usher's syndrome: ophthalmic and neuro-otologic findings suggesting genetic heterogeneity. Arch Ophthalmology. 1983;101:1367-1374.
14. Piazza L, Fishman GA, Farber M, Derlacki D, Anderson RJ. Visual acuity loss in patients with Usher's syndrome. Arch Ophthalmol. 1986;104:1336-1339.
15. Tsilou ET, Rubin BI, Caruso RC, et al. Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand. 2002;80:196-201.
16. Iannaccone A, Kritchevsky SB, Ciccarelli ML, et al. Kinetics of visual field loss in Usher syndrome type II. Invest Ophthalmol Vis Sci. 2004;45:784-792.
17. Pennings RJ, Huygen PL, Orten DJ, et al. Evaluation of visual impairment in Usher syndrome 1b and Usher syndrome 2a. Acta Ophthalmol Scand. 2004;82:131-139.
18. Schwartz SB, Aleman TS, Cideciyan AV, et al. Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype. Invest Ophthalmol Vis Sci. 2005;46:734-743.
19. Herrera W, Aleman TS, Cideciyan AV, et al. Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol Vis Sci. 2008;49:2651-2660.
20. Lopes VS, Gibbs D, Libby RT, et al. The Usher 1B protein, MYO7A, is required for normal localization and function of the visual retinoid cycle enzyme, RPE65. Hum Mol Genet. 2011;20:2560-2570.
21. Jacobson SG, Yagasaki K, Feuer WJ, Román AJ. Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa. Exp Eye Res. 1989;48:679-691.
22. Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG. Spinocerebellar ataxia type 7(SCA7) shows a cone-rod dystrophy phenotype. Exp Eye Res. 2002;74:737-745.
23. Jacobson SG, Voigt WJ, Parel JM, et al. Automated light-and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986;93:1604-1611.
24. Roman AJ, Schwartz SB, Aleman TS, et al. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Exp Eye Res. 2005;80:259-272.
25. Jacobson SG, Cideciyan AV, Regunath G, et al. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat Genet. 1995;11:27-32.
26. Cideciyan AV, Pugh EN Jr, Lamb TD, Huang Y, Jacobson SG. Rod plateaux during dark adaptation in Sorsby's fundus dystrophy and vitamin A deficiency. Invest Ophthalmol Vis Sci. 1997;38:1786-1794.
27. Cideciyan AV, Zhao X, Nielsen L, Khani SC, Jacobson SG, Palczewski K. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc Natl Acad Sci U S A. 1998;95:328-333.
28. Cideciyan AV, Hood DC, Huang Y, et al. Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci USA. 1998;95:7103-7108.
29. Cideciyan AV, Haeseleer F, Fariss RN, et al. Rod and cone visual cycle consequences of a null mutation in the 11-cis-retinol dehydrogenase gene in man. Vis Neurosci. 2000;17:667-678.
30. Jacobson SG, Cideciyan AV, Wright E, Wright AF. Phenotypic marker for early disease detection in dominant late-onset retinal degeneration. Invest Ophthalmol Vis Sci. 2001;42:1882-1890.
31. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525-534.
32. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA. 2008;105: 15112-15117.
33. Huang Y, Cideciyan AV, Papastergiou GI, et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39:2405-2416.
34. Jacobson SG, Cideciyan AV, Aleman TS, et al. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum Mol Genet. 2003;12:1073-1078.
35. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2005;102: 6177-6182.
36. Aleman TS, Cideciyan AV, Sumaroka A, et al. Retinal laminar architecture in human retinitis pigmentosa caused by rhodopsin gene mutations. Invest Ophthalmol Vis Sci. 2008;49:1580-1590.
37. Coureux PD, Sweeney HL, Houdusse A. Three myosin V structures delineate essential features of chemo-mechanical transduction. EMBO J. 2004;23:4527-4537.
38. Hubbard T, Barker D, Birney E, et al. The Ensembl genome database project. Nucleic Acids Res. 2002;30:38-41.
39. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497-523.
40. Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol. 1985;99:240-251.
41. Massof RW, Finkelstein D. A two-stage hypothesis for the natural course of retinitis pigmentosa. Adv Biosci. 1987;52:29-58.
42. Birch DG, Anderson JL, Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 1999;106:258-268.
43. Sakami S, Maeda T, Bereta G, et al. Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J Biol Chem. 2011;286:10551-10567.
44. Clarke G, Collins RA, Leavitt BR, et al. A one-hit model of cell death in inherited neuronal degenerations. Nature. 2000;406:195-199.
45. Wu L, Pan L, Wei Z, Zhang M. Structure of MyTH4-FERM domains in myosin VIIa tail bound to cargo. Science. 2011;331(6018):757-760.
46. Grover S, Fishman GA, Anderson RJ, Alexander KR, Derlacki DJ. Rate of visual field loss in retinitis pigmentosa. Ophthalmology. 1997;104:460-465.
47. Jacobson SG, Aleman TS, Cideciyan AV, et al. Defining the residual vision in Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2009;50:2368-2375.
48. Fishman GA, Bozbeyoglu S, Massof RW, Kimberling W. Natural course of visual field loss in patients with Type 2 Usher syndrome. Retina. 2007;27:601-608.
49. Edwards A, Fishman GA, Anderson RJ, Grover S, Derlacki DJ. Visual acuity and visual field impairment in Usher syndrome. Arch Ophthalmol. 1998;116:165-168.
50. Ebermann I, Phillips JB, Liebau MC, et al. PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. J Clin Invest. 2010;120:1812-1823.
51. Khanna H, Davis EE, Murga-Zamalloa CA, et al. A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Nat Genet. 2009;41:739-745.
52. Louie CM, Caridi G, Lopes VS, et al. AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat Genet. 2010;42:175-180.
53. Mburu P, Liu XZ, Walsh J, et al. Mutation analysis of the mouse myosin VIIA deafness gene. Genes Funct. 1997;1:191-203.
54. Liu X, Udovichenko IP, Brown SD, Steel KP, Williams DS. Myosin VIIa participates in opsin transport through the photoreceptor cilium. J Neurosci. 1999;19:6267-6274.
55. Hasson T, Walsh J, Cable J, Mooseker MS, Brown SDM, Steel KP. Effects of shaker-1 mutations on myosin-VIIa protein and mRNA expression. Cell Motil Cytoskeleton. 1997;37:127-138.
56. Schwander M, Lopes V, Sczaniecka A, et al. A novel allele of myosin VIIa reveals a critical function for the C-terminal FERM domain for melanosome transport in retinal pigment epithelial cells. J Neurosci. 2009;29:15810-15818.
57. Yang Y, Baboolal TG, Siththanandan V, et al. A FERM domain autoregulates Drosophila myosin 7a activity. Proc Natl Acad Sci U S A. 2009;106:4189-4194.
58. Sakai T, Umeki N, Ikebe R, Ikebe M. Cargo binding activates myosin VIIA motor function in cells. Proc Natl Acad Sci U S A. 2011;108:7028-7033.
59. Rhodes CR, Hertzano R, Fuchs H, et al. A Myo7a mutation cosegregates with stereocilia defects and low-frequency hearing impairment. Mamm Genome. 2004;15:686-697.
60. Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol. 1997;4(3):311-323.